Relmada Therapeutics (RLMD) Gains (Losses) on Sale of Assets & Investments (2020 - 2026)
Relmada Therapeutics' Gains (Losses) on Sale of Assets & Investments came in at -$167,258 for Q2 2026, compared with $47,203 a year earlier.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Gains (Losses) on Sale of Assets & Investments (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Relmada Therapeutics reported Gains (Losses) on Sale of Assets & Investments of -$602,748; for FY2025, it was $398,255, up 6.2% from FY2024.
- Going back by year, Gains (Losses) on Sale of Assets & Investments was $374,926 in FY2024, -$4.06 million in FY2023, -$4.22 million in FY2022 and -$636,012 in FY2021.
- The five-year range for quarterly Gains (Losses) on Sale of Assets & Investments is -$3.35 million (Q4 2023) to $1.29 million (Q1 2023).
- Business Quant data shows RLMD's Gains (Losses) on Sale of Assets & Investments at -$540,097 (Q1 2026), $186,045 (Q4 2025) and -$81,438 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | -167,258.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -167,258.00 |
| Mar 31, 2026 | -540,097.00 |
| Dec 31, 2025 | 186,045.00 |
| Sep 30, 2025 | -81,438.00 |
| Jun 30, 2025 | 47,203.00 |
| Mar 31, 2025 | 155,731.00 |
| Dec 31, 2024 | 40,844.00 |
| Sep 30, 2024 | 278,555.00 |
| Jun 30, 2024 | 133,114.00 |
| Mar 31, 2024 | 53,133.00 |
| Dec 31, 2023 | -3.35 Mn |
| Sep 30, 2023 | -579,147.00 |
| Jun 30, 2023 | -639,634.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | -323,120.00 |
| Sep 30, 2022 | -947,512.00 |
| Jun 30, 2022 | -1.19 Mn |
| Mar 31, 2022 | -1.76 Mn |
| Dec 31, 2021 | -122,684.00 |
| Sep 30, 2021 | -336,949.00 |
API Access
Relmada Therapeutics Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();